Fulcrum Therapeutics Leadership

Robert J. Gould is a Director at Hemoshear and President and Chief Executive Officer at FULCRUM THERAPEUTICS INC. and is based in Cambridge, Massachusetts.

Esther Rajavelu joined Fulcrum in January 2022 as chief financial officer with nearly 20 years of experience in the life sciences sector spanning equities research, investment banking and strategic consulting. She was previously a senior equities research analyst at UBS Securities covering small-cap and mid-cap biotechnology companies. She also covered biotechnology and pharmaceutical companies as an analyst at Deutsche Bank and Oppenheimer & Co. Prior to her career in equities research, she spent several years as an investment banker focused on life sciences companies at leading financial institutions including Bank of America Merrill Lynch and EY Capital Advisors. Esther began her career as a pharmaceuticals strategy consultant. She earned a bachelor’s degree in economics and international relations from Wesleyan University and an MBA from the Wharton School of the University of Pennsylvania.

Robert J. Gould is a Director at Hemoshear and President and Chief Executive Officer at FULCRUM THERAPEUTICS INC. and is based in Cambridge, Massachusetts.

Esther Rajavelu joined Fulcrum in January 2022 as chief financial officer with nearly 20 years of experience in the life sciences sector spanning equities research, investment banking and strategic consulting. She was previously a senior equities research analyst at UBS Securities covering small-cap and mid-cap biotechnology companies. She also covered biotechnology and pharmaceutical companies as an analyst at Deutsche Bank and Oppenheimer & Co. Prior to her career in equities research, she spent several years as an investment banker focused on life sciences companies at leading financial institutions including Bank of America Merrill Lynch and EY Capital Advisors. Esther began her career as a pharmaceuticals strategy consultant. She earned a bachelor’s degree in economics and international relations from Wesleyan University and an MBA from the Wharton School of the University of Pennsylvania.

Robert J. Gould is a Director at Hemoshear and President and Chief Executive Officer at FULCRUM THERAPEUTICS INC. and is based in Cambridge, Massachusetts.